RBM10 modulates apoptosis and influences TNF-α gene expression

Journal of Cell Death

Volumn 5, Issue , 2012, Pages 1-19

  Wang, Ke ^a,d   Bacon, Mackensey L ^a   Tessier, Julie J ^a   Rintala Maki, Nina D ^a   Tang, Vanessa ^a   Sutherland, Leslie C ^a,b,c  

^a North East Cancer Centre   (India)

^b LAURENTIAN UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; RBM10; RBM5; TNF alpha; Transcription

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RNA BINDING MOTIF 10; RNA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RNA EXTRACTION; RNA INTERFERENCE; RNA STABILITY; SIGNAL TRANSDUCTION; STOP CODON; TRANSCRIPTION REGULATION;

EID: 84863234128     PISSN: None     EISSN: 11790660     Source Type: Journal    
DOI: 10.4137/JCD.S907     Document Type: Article

References (42)

1. Timmer T, Terpstra P, van den Berg A et al. An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers. Genomics. 1999;60:238-240.
2. Bonnal S, Martinez C, Forch P, Bachi A, Wilm M, Valcarcel J. RBM5/ Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell. 2008;32:81-95.
3. Martinez-Arribas F, Agudo D, Pollan M et al. Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem. 2006;97:1275-1282.
4. Martin-Garabato E, Martinez-Arribas F, Pollan M, Lucas AR, Sanchez J, Schneider J. The small variant of the apoptosis-associated X-chromosome RBM10 gene is co-expressed with caspase-3 in breast cancer. Cancer Genomics Proteomics. 2008;5:169-73.
5. James CG, Ulici V, Tuckermann J, Underhill TM, Beier F. Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC Genomics. 2007;8:205.
6. Behzadnia N, Golas MM, Hartmuth K et al. Composition and threedimensional EM structure of double affinity-purified, human prespliceosomal A complexes. EMBO J. 2007;26:1737-48.
7. Deckert J, Hartmuth K, Boehringer D et al. Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions. Mol Cell Biol. 2006;26:5528-43.
8. Herold N, Will CL, Wolf E, Kastner B, Urlaub H, Luhrmann R. Conservation of the protein composition and electron microscopy structure of {Eth}rosophila melanogaster and human spliceosomal complexes. Mol Cell Biol. 2009;29:281-301.
9. Loughlin FE, Mansfield RE, Vaz PM et al. The zinc fingers of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that recognize 5′ splice site-like sequences. Proc Natl Acad Sci U S A. 2009;106:5581-86.
10. Sutherland LC, Rintala-Maki ND, White RD, Morin CD. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? J Cell Biochem. 2005;94:5-24.
11. Rintala-Maki ND, Sutherland LC. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis. 2004;9:475-84.
12. Rintala-Maki ND, Abrasonis V, Burd M, Sutherland LC. Genetic instability of RBM5/LUCA-15/H37in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem Funct. 2004;22:307-13.
13. Sutherland LC, Edwards SE, Cable HC et al. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene. 2000;19:3774-81.
14. Mc Gee MM, Hyland E, Campiani G, Ramunno A, Nacci V, Zisterer DM. Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6. FEBS Lett. 2002;515:66-70.
15. Williams GT, Critchlow MR, Hedge VL, O'Hare KB. Molecular failure of apoptosis: inappropriate cell survival and mutagenesis? Toxicol Lett. 1998;102-103:485-9.
16. Chen Q, Zhao Y, Cheng Z, Xu Y, Yu C. Establishment of a cell-based assay for examining the expression of tumor necrosis factor alpha (TNF-alpha) gene. Appl Microbiol Biotechnol. 2008;80:357-63.
17. Ding Y, Huang Y, Song N et al. NFAT1mediates placental growth factorinduced myelomonocytic cell recruitment via the induction of TNF-alpha. J Immunol. 2010;184:2593-601.
18. Polak PE, Simone F, Kaberlein JJ, Luo RT, Thirman MJ. ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia. Mol Biol Cell. 2003;14:1517-28.
19. Sutherland LC, Lerman M, Williams GT, Miller BA. LUCA-15suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene. 2001;20:2713-9.
20. Sutherland LC, Lerman M, Williams GT, Miller BA. LUCA-15suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene. 2004;23:629.
21. Mourtada-Maarabouni M, Sutherland LC, Williams GT. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. Apoptosis. 2002;7:421-32.
22. Inoue A, Tsugawa K, Tokunaga K et al. S1-1 nuclear domains: characterization and dynamics as a function of transcriptional activity. Biol Cell. 2008.
23. Mueller CF, Berger A, Zimmer S, Tiyerili V, Nickenig G. The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms. Arch Biochem Biophys. 2009;488:76-82.
24. Takei S, Redford A, Katayama S, Toyoda H. Destabilization of tumor necrosis factor-alpha mRNA by 5-alpha dihydrotestosterone in Jurkat cells. Life Sci. 2000;66:L277-82.
25. Kar A, Havlioglu N, Tarn WY, Wu JY. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J Biol Chem. 2006;281: 24479-88.
26. Lin JC, Tarn WY. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. J Cell Biol. 2011;193:509-20.
27. Lallena MJ, Chalmers KJ, Llamazares S, Lamond AI, Valcarcel J. Splicing regulation at the second catalytic step by Sex-lethal involves 3' splice site recognition by SPF45. Cell. 2002;109:285-296.
28. Seth P, Yeowell HN. Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2messenger RNA. Arthritis Rheum. 2010;62:1167-75.
29. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181-90.
30. Bremer E, de BM, Wajant H, Helfrich W. Targeted cancer immunotherapy using ligands of the tumor necrosis factor super-family. Curr Drug Targets. 2009;10:94-103.
31. Stumpo DJ, Lai WS, Blackshear PJ. Inflammation: cytokines and RNA- based regulation. Wiley Interdiscip Rev RNA. 2010;1:60-80.
32. Piecyk M, Wax S, Beck AR et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 2000;19:4154-63.
33. Black RA, Rauch CT, Kozlosky CJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729-33.
34. Moss ML, Jin SL, Milla ME et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997;385:733-6.
35. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993;62:289-321.
36. Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol. 1999;11:363-71.
37. Weighardt F, Biamonti G, Riva S. The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays. 1996;18:747-56.
38. Suswam EA, Li YY, Mahtani H, King PH. Novel DNA-binding properties of the RNA-binding protein TIAR. Nucleic Acids Res. 2005;33:4507-18.
39. Doi T, Minami T, Itoh M et al. An alternative form of nucleolysin binds to a T-cluster DNA in the silencer element of platelet factor 4gene. Biochem Biophys Res Commun. 1997;235:625-30.
40. Duncan R, Collins I, Tomonaga T, Zhang T, Levens D. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the singlestrand-binding protein FBP. Mol Cell Biol. 1996;16:2274-82.
41. Michelotti EF, Michelotti GA, Aronsohn AI, Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol. 1996;16:2350-60.
42. Fushimi K, Ray P, Kar A, Wang L, Sutherland LC, Wu JY. Up-regulation of the proapoptotic caspase 2splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci U S A. 2008;105:15708-13.